Future Of Packaging In 2030
Express Pharma|February 01-15, 2020
Pharma packaging is an ever-evolving yet challenging segment of the pharma industry. Business insights from the last decade will help the industry in visualising the need of the sector with high reliability and sustainability solutions with low-cost methods. Express Pharma presents the industry’s views, understanding, and preparedness for the next decade.
Usha Sharma

Serialisation is the buzzword transforming pharma packaging industry

Pharma packaging is one such pillar for business development which has evolved and is still evolving in an accelerated pace. The motive has been defined differently from time to time from containment and protection, to branding to user-friendliness.

Now is the era where the business perspectives are driven through regulatory compliance, customer focus, and environmental sustainability. So maintaining the same packaging should also be designed with a purpose to meet the mentioned perspective as

Regulatory compliance

Regulatory changes are driving packaging innovation globally. Track and trace of the products throughout the supply chain to address the counterfeit issues. Serialisation is the buzz word transforming pharmaceutical packaging industry.

Evolving Product Composition – Rethinking Primary Packaging

These days the focus is on biologic drugs. Most biologic drugs being injectables; glass is the logical choice for primary packaging. However, some biologic drugs are found to interact with glass, delaminate it, causing flaking. So, it is necessary to keep this in mind while developing the primary packaging.

Customer focus and intelligent packaging

An ageing population and increasing life expectancy provides room for packaging innovation. While digital medicine with in-built sensors is making inroads in compliance monitoring and connected care, features such as daily dose markings on the pack are common, advanced features such as digital timers and alarms on packaging reminding patients of the time for next dose are the need of the hour.

Accurate dosing and dose monitoring: Dose monitoring features in packaging are increasingly playing an important role in abuse deterrence as well as patient adherence. Simple metered dosing systems to calendar-enabled closure technologies tracking and counting pills as they are dispensed and send the data to a smartphone. Unitdose packaging with key drug details incorporated in every dose is gaining popularity in hospitals and clinics as a convenient and safe option, driving allied trends in packaging.

Tamper protection and Child Lock: With a high contribution of pharmaceuticals unintentional childhood poisoning, need for child locking mechanisms is critical. Packaging industries continue to incrementally innovate in striking the right balance between making it inaccessible to children but not too difficult for elderly patients. Several innovative packaging mechanisms are evolving in pharmaceutical packaging, including braille printing for blind people

Sustainability: Lot of packaging waste generated gets dumped into ocean, destroying marine life. In the process, it is destroying the ecological balance.

Business will sustain with its people and mankind will sustain only with a safe and healthy environment. Packaging shall be designed in a way to meet the three main mantras Reduce, reuse and recycle.

Packaging has a profound impact across the entire supply chain

The Indian pharmaceutical industry is undergoing significant growth. Even at current rates of seven to eight per cent CAGR, the industry’s annual revenues can grow to about USD 80 to 90 billion by 2030. As we enter in the new decade, pharma will continue to face the challenges from the past. Particularly, the globalisation of drug supply, delivering new product types, meeting demand from emerging countries, the rise of chronic lifestyle conditions such as obesity and diabetes, and the growing threat of counterfeit and falsified medicine.

To fulfill these requirements, the demand for pharma packaging products will rapidly evolve in the next three to seven years as portfolio diversification strategies translate to revenue realisation milestones. This will drive expanded demand in several products categories across primary and secondary packaging.

In the coming decade, there will be numerous changes within the pharma industry:

1. Increasing in the number of complex formulations

2. More active engagement in biopharmaceuticals

3. Increasing price pressure and competition within generics, regulatory changes and critical emphasis on the product safety and integrity

4. Increasing the focus on patient-centricity etc.

ANDA Filled by Indian generic companies – (December 2019)

A- Solidoral doses
B- Injectable
C- Ophthalmic
D- Others (Inhalation, topical, Transdermal etc.)

The above chart shows that about 85-90 per cent of the ANDAs held by Indian pharma companies are comprised of oral solids but there is a planned shift towards more complex molecules whose packaging is not only complex but also should be based on patient safety, patient compliance and patient convenience as well as patient-centric, intelligent and smart packaging for coming decade.

So, in the face of such disruption, we can expect some leading developments from Pharma packaging in the coming decade.

A) Focus on patient safety, compliance and convenience.

The patient today has progressed from being the passive recipient of drugs to an active partner in the entire drug development process, right from the formulation type to the type of packaging. Digitalisation and awareness through social media have been the key driver of this change and the industry has been proactive in recognising the importance of ‘patientcentricity’, better to put as ‘customer-centricity’.

Some examples of patient safety, compliance and convenience pack

◗ Child-resistant packaging and Senior Friendly packaging

◗ Wallet pack

◗ Unit dose packaging with CR features. Unit dose packaging to avoid contamination of the drug product

◗ Child-resistant medication with timer or alarm caps

B) Smart Packaging and intelligent packaging

Embedding advanced features into packaging such as sensing or wireless communication makes packaging ‘smart’ which can provide significant functionality. The packaging then becomes not only a way to protect and provide information on medicines but can add a whole host of extra functionality. The smart packaging can reduce supply chain losses through enhanced environmental monitoring and support improved patient adherence through smart adherence packaging.

For an example – Smart Bottle uses Biometric (fingerprint) authorisation to ensure that patients—and only patients—receive their prescribed doses of liquid opioid medications. If an unauthorised user tries to tamper with or force-dispense medication from the Smart Bottle, the device immediately neutralises the opioid.

C) Device and self-administration

Changing in hospital administration to self-administration process is increasing rapidly in the market. So, the medical devices are taking the leading role for the coming decade.

D) Connecting device

A connected medical device can collect and store data about patient use and trace the effectiveness of a particular device and treatment to help them to do so.

Utilising connectivity in drug delivery devices such as injectors and inhalers, connected health solutions help pharmaceutical companies, healthcare professionals and patients, improve how people take their medication. In addition to medication tracking, these systems support patients through reminders, incentives and peer communities to improve disease management, medication adherence and, ideally, outcomes. Additionally to this, we hope the connecting device will be used for the emergency treatment of the patient in the coming decade with a secure channel.

E) Blow fill seal(BFS) for unit dose stérile product

The inherent safety of the process, packaging sterile products under aseptic conditions without human intervention, has led the FDA to characterise Blow/Fill/Seal technology as an "advanced aseptic process", indicating its use as a preferred technology going forward for thecoming decade.

G) IoT (Internet of Things)

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM EXPRESS PHARMAView All

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

9 mins read
Express Pharma
August 2021

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

2 mins read
Express Pharma
August 2021

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

6 mins read
Express Pharma
August 2021

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

3 mins read
Express Pharma
August 2021

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

4 mins read
Express Pharma
August 2021

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

4 mins read
Express Pharma
August 2021

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

2 mins read
Express Pharma
August 2021

It's important to enhance customer experience so that existing customers are more loyal

Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer experience, and how the right CRM solution can help companies to identify, address and manage customer expectations more effectively, in an interaction with Viveka Roychowdhury

5 mins read
Express Pharma
August 2021

From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice

Arun Kedia, Managing Director,VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment

4 mins read
Express Pharma
August 2021

Ensuring pharma compliance with testo data loggers

Testo data loggers can be used to test the optimum conditions for specific products or surroundings

2 mins read
Express Pharma
August 2021